Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

526
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
526
Bipolar Disorder01:30

Bipolar Disorder

586
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
586
Drug Therapy01:28

Drug Therapy

229
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
229
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

436
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
436
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

780
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
780
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

216
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
216

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter to editor: Bipolar disorders.

Bipolar disorders·2023
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.2K

At 75 Years, Is Lithium the Gold Standard in Bipolar Disorder?

Robert H Belmaker1

  • 1Department of Psychiatry, Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheva 8410501, Israel.

Pharmaceuticals (Basel, Switzerland)
|December 31, 2025
PubMed
Summary

Lithium, antiepileptics, and antipsychotics effectively treat bipolar disorder phases. However, their diverse mechanisms highlight lithium

Keywords:
antiepilepticsbipolar disordergold standardlithiumlithium responsemechanism of actionsecond-generation antipsychotics

More Related Videos

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

82.9K
Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

10.1K

Related Experiment Videos

Last Updated: Jan 7, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.2K
The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

82.9K
Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

10.1K

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Lithium is the first mood stabilizer for bipolar disorder.
  • Antiepileptics (e.g., valproate, carbamazepine) and second-generation antipsychotics are also effective in all bipolar disorder phases.
  • These treatments lack a common mechanism of action.

Purpose of the Study:

  • To review the efficacy and mechanisms of lithium, antiepileptics, and antipsychotics in bipolar disorder treatment.
  • To critically evaluate the role of lithium as a "gold standard" treatment.

Main Methods:

  • Literature review and synthesis of existing research on mood stabilizers for bipolar disorder.
  • Analysis of biochemical effects and clinical applications of lithium, antiepileptics, and antipsychotics.

Main Results:

  • Lithium, antiepileptics, and antipsychotics demonstrate comparable efficacy across bipolar disorder phases.
  • Lithium exhibits numerous biochemical effects, but a unified mechanism remains elusive.
  • The efficacy of other drug classes challenges lithium's unique status.

Conclusions:

  • Lithium is a useful, but nonspecific, treatment for bipolar disorder and other conditions.
  • Current evidence does not support lithium as a "gold standard" due to the efficacy of other agents.
  • Further research is needed to elucidate shared and distinct mechanisms of action for mood stabilizers.